Physiomics (PYC)

 

PYC Share PerformanceMore

52 week high17.5000 01/12/17
52 week low0.9190 26/10/17
52 week change 3.3250 (271.43%)
4 week volume30,784,936 30/04/18
price4.5500
price date1527261803
close4.5500

Latest NewsMore

Placing

RNS Number: 9499O Physiomics PLC 23 May 2018 Physiomics plc ("Physiomics") or ("the Company") Placing Physiomics completes placing to fund growth opportunities Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to announce that it has completed a p...

Contract Award

RNS Number: 2422M Physiomics PLC 26 April 2018 26 th April 2018 Physiomics plc ("Physiomics") or ("the Company") Contract award Physiomics signs agreement with new biotech client Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is delighted to announce tha...

Director/PDMR Shareholding

RNS Number: 1567K Physiomics PLC 06 April 2018 Physiomics plc ("Physiomics") or ("the Company") Director Dealing The Company announces that it received notice today that Dr Chassagnole (COO) transferred paper share certificates of 121,522 shares and 265,111 shares to his nominee account 'Interactive Investor Services Nominees Limited'. Following the transfer...

Physiomics to Present at AACR Annual Meeting

RNS Number: 6692J Physiomics PLC 04 April 2018 Physiomics Plc The Magdalen Centre The Oxford Science Park Robert Robinson Avenue Oxford OX4 4GA UK 4 th April 2018 Physiomics Plc ("Physiomics" or "the Company") Physiomics to Present at the American Association for Cancer Research ("AACR") Annual Meeting Physiomics plc (AIM: PYC), a provide...

Issue of Options

RNS Number: 1474J Physiomics PLC 27 March 2018 Physiomics plc ("Physiomics") or ("the Company") Issue of Options The Company considers that the award of options linked to company performance are critical to the incentivisation of its senior employees and to ensure that there is alignment between management and shareholders. To this end, the Company tod...

Physiomics wins UK government grant for cancer treatment study

Physiomics, a provider of technology-based solutions to predict the effects of cancer treatment regimens, said it had been a...

Award of New Innovate UK Grant

RNS Number: 6050H Physiomics PLC 14 March 2018 Physiomics plc ("Physiomics") or ("the Company") Award of New Innovate UK Grant Feasibility study to optimise individual patient dosing in prostate cancer in new era of precision medicine Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens, ...

Physiomics completes UK grant project for cancer treatment

Physiomics said it had successfully completed a UK grant project related to improving cancer treatments that received 131k...

Fundamental DataMore

EPS-0.78
Dividend yield0 %

Latest discussion posts More

  • Re: PYC will be big - part 2

    At a price of 6.15p, the company is valued at a lowly #3.6mln, but Millen points out that is five times more than a year ago. Millen SHOULD also point out...????...but ...
    21-May-2018
    inforapoundtoo
  • Re: PYC will be big - part 2

    Personalised Medicine Innovate UK?s grants were for studies in personalised medicine, which involves treating individuals or groups in a specific way rather than a one-size ...
    17-May-2018
    dickie3times
  • PYC will be big

    Physiomics PLC: Personalised medicines will build on momentum from recent pharma deals To clarify, this is not the US pharma supermajor Merck but an unrelated German firm also ...
    17-May-2018
    dickie3times

Users' HoldingsMore

Users who hold Physiomics also hold..

Codes & Symbols

ISINGB00BDR6W943
SymbolsPYC, LSE:PYC, PYC.L, PYC:LN, LON:PYC, XLON:PYC